CARVILIN 12.5 / 6.25 TAB (Carvedilol 12.5 mg / 6.25 mg Tablets)
For Regaining heart health
Carvedilol
Beta) adrenoreceptor blocking activity.
Percent in S (-) enantiomer
Suppresses reninangiotensin through non-Selective Beta -blokade
a1-adrenergic blocking activity
present in R(+) and S (-) enantiomers at equal potency
Reduces the peripheral vascular resistance
INDICATION
For mild-to- severe chronic heart failure of ischemic or cardiomyopathic origin (Usually in addition to diuretics, ACE inhibitors, and Digitalis)
In left Ventricular dysfunction following myocardial infarction
For the management of essential hypertension (as alone or in combination with other anti hypertensive agents, especially thiazide -type diuretics)
Dosage
Heart failure - 3.215 mg Twice daily for 2 weeks
Hypertension - 6.25 mg Twice daily
Left Ventricular dysfunction following myocardial infarction 6.25mg Twice daily
Company: LINCOLN